Alchemedicine

About:

Alchemedicine is a biotechnology company that conducts internal and joint drug research and discovery programs.

Top Investors: SMBC Venture Capital, Mitsubishi UFJ Capital, Beyond Next Ventures, JAFCO, Joyo Bank

Description:

Alchemedicine is a the world in drug discovery with unique technologies and ideas Innovating new drug candidates for diseases with high unmet medical needs.

Total Funding Amount:

1.01B JPY

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Tsukuba, Ibaraki, Japan

Founded Date:

2019-02-25

Founders:

Keigo Tanaka

Number of Employees:

1-10

Last Funding Date:

2021-02-16

IPO Status:

Private

Industries: